{
    "Trade/Device Name(s)": [
        "OralTox\u00ae Oral fluid Drug Test"
    ],
    "Submitter Information": "Premier Biotech Inc",
    "510(k) Number": "K181305",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171403",
        "K002010",
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJC",
        "DJG",
        "DIO",
        "DKZ",
        "LCM",
        "LDJ",
        "DJR"
    ],
    "Summary Letter Date": "August 9, 2018",
    "Summary Letter Received Date": "August 10, 2018",
    "Submission Date": "September 19, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3610",
        "21 CFR 862.3250",
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system",
        "Cocaine test system",
        "Opiate test system",
        "Amphetamine test system",
        "Cannabinoids test system",
        "Methadone test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Cocaine",
        "Marijuana (THC)",
        "Methamphetamine",
        "Opiates",
        "Phencyclidine",
        "Oxycodone",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Test cup",
        "Sample collection sponge"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for OralTox Oral fluid Drug Test, a lateral flow immunochromatographic device for qualitative detection of multiple drugs of abuse in oral fluid.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of amphetamine, cocaine, marijuana (THC), methamphetamine, opiates, phencyclidine, oxycodone, and methadone and their metabolites in human oral fluid; preliminary test requiring confirmatory method for positive results.",
    "fda_folder": "Toxicology"
}